BTW
JAZZ icon

Boston Trust Walden’s Jazz Pharmaceuticals JAZZ Stock Holding History

Boston Trust Walden’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107M Sell
443,123
-45,538
-9% -$9.98M 0.81% 25
2026
Q1 		$92.4M Buy
488,661
+94,750
+24% +$16.6M 0.76% 29
2025
Q4 		$67M Sell
393,911
-14,916
-4% -$2.29M 0.51% 67
2025
Q3 		$53.9M Buy
408,827
+930
+0.2% +$112K 0.4% 100
2025
Q2 		$43.3M Buy
407,897
+229,885
+129% +$25M 0.31% 131
2025
Q1 		$22.1M Buy
+178,012
New +$23.2M 0.16% 171

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Boston Trust Walden's JAZZ Position: Q2 2026 in Review

Boston Trust Walden reduced its Jazz Pharmaceuticals (JAZZ) stake by 9.3% in Q2 2026, selling an estimated $9.98M and leaving 443,123 shares worth $107M. The position accounts for 0.81% of the portfolio, ranked #25.

Boston Trust Walden first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. 643 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Boston Trust Walden held 443,123 shares of Jazz Pharmaceuticals worth $107M as of Q2 2026.
  • Boston Trust Walden sold 45,538 Jazz Pharmaceuticals shares in Q2 2026, an estimated $9.98M.
  • Jazz Pharmaceuticals made up 0.81% of Boston Trust Walden's portfolio in Q2 2026, its #25 holding.
  • Boston Trust Walden first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 643 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.